Morris Corporate Center 1 Building C, 300 Interpace Parkway Parsippany, NJ 07054 www.pdi-inc.com
Interpace Diagnostics Group's annual revenues are $100-$500 million (see exact revenue data) and has 100-500 employees. It is classified as operating in the Drugs & Druggists' Sundries Merchant Wholesalers industry.
Note: Interpace Diagnostics Group's revenues are gauged from an analysis of company filings.
Interpace Diagnostics Group has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
January 27, 2020
Complete list of funding rounds and total amounts in the Company Report
Trademark applications show the products and services that Interpace Diagnostics Group is developing and marketing.
Interpace Diagnostics Group's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets.
Trademarks may include brand names, product names, logos and slogans.
SERACOV Diagnostic testing of bodily fluids for use in antibody detection, namely, for identifying antibodies that neutralize the COVID-19 virus in patient blood samples
COVIANT Diagnostic testing of bodily fluids for use in antibody detection, namely, for identifying antibodies that neutralize the COVID-19 virus in patient blood samples
INTERPACE PHARMA SOLUTIONS laboratory services for pharmaceutical development
Determine whether Interpace Diagnostics Group grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Interpace Diagnostics Group is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of Interpace Diagnostics Group's Largest Competitors
A competitive analysis shows these companies are in the same general field as Interpace Diagnostics Group, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Interpace Diagnostics Group.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Interpace Diagnostics Group and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.